B03XA02 • darbepoetin alfa • Blood and blood forming organs | Other antianemic preparations
Darbepoetin alfa is an erythropoiesis-stimulating agent used for the treatment of anemia associated with chronic kidney disease and chemotherapy. It works by stimulating the production of red blood cells in the bone marrow, helping to increase hemoglobin levels.
The medication is administered via subcutaneous or intravenous injection, usually once weekly or at longer intervals, depending on the patient's response. Common side effects include high blood pressure, headaches, and edema.
Darbepoetin alfa is contraindicated in patients with uncontrolled hypertension or hypersensitivity to the active substance. Its use also requires careful monitoring to prevent cardiovascular complications.
This medication is an effective option for managing anemia, helping to improve the quality of life for affected patients.
Substance: darbepoetin alfa
Date of last drug list: 01-07-2020
Commercial code: W41531002
Concentration: 150mcg / 0.3ml
Pharmaceutical form: injection solution in pre-filled syringe
Quantity: 4
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).